A detailed history of Harbour Investments, Inc. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Harbour Investments, Inc. holds 26 shares of RDY stock, worth $376. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26
Previous 26 -0.0%
Holding current value
$376
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 16, 2024

SELL
$64.27 - $69.9 $48,202 - $52,425
-750 Reduced 96.65%
26 $1,000
Q3 2023

Nov 15, 2023

BUY
$61.9 - $72.77 $46,425 - $54,577
750 Added 2884.62%
776 $51,000
Q2 2023

Aug 14, 2023

BUY
$53.34 - $63.11 $1,386 - $1,640
26 New
26 $1,000
Q4 2021

Feb 16, 2022

SELL
$59.5 - $67.25 $2,320 - $2,622
-39 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$60.19 - $75.29 $60 - $75
1 Added 2.63%
39 $3,000
Q1 2021

Aug 17, 2021

BUY
$57.98 - $73.08 $2,203 - $2,777
38 New
38 $2,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.4B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.